Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry

24 Feb 2023

Abstract excerpt

Background: The outcome of COVID-19 in allogeneic hematopoietic stem cell transplantation (HSCT) recipients is almost uniformely considered poor. The aim of present study was to retrospectively analyse the outcome and risk factors for mortality in a large series of patients who developed COVID-19 infection after an allogeneic HSCT. Methods: This multicenter retrospective study promoted by the European Hematology...

Topics

Join the communities discussing this publication.

COVID-19 and healthcare impacts
COVID-19 Clinical Research Studies
Hematopoietic Stem Cell Transplantation

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 36911708
DOI: 10.3389/fimmu.2023.1125030

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registryPMID 36911708Read ↗

The outcome of hematopoietic stem cell transplantation patients with COVID-19 infectionSemantic proximity Read ↗

Clinical course and outcomes of COVID‐19 in hematopoietic cell transplant patients, a regional report from the Middle EastSemantic proximity Read ↗

Prognosis of patients after organ transplantation during active COVID-19 infectionSemantic proximity Read ↗

COVID-19 infection in hematopoietic cell transplantation: age, time from transplant and steroids matterSemantic proximity Read ↗

COVID-19 pandemic and impact on hematopoietic stem cell transplantationSemantic proximity Read ↗

Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factorsSemantic proximity Read ↗

Clinical Presentations and Outcomes in Transplant Patients With COVID-19: A Systematic Review and Meta-AnalysisSemantic proximity Read ↗

"Unusual" viral diseases after allogeneic hematopoietic stem cell transplantation: a multicenter, retrospective studySemantic proximity Read ↗

Spotlight on the impact of viral infections on Hematopoietic Stem Cells (HSCs) with a focus on COVID-19 effectsSemantic proximity Read ↗

Crucial Aspects of the Management of Solid Organ Transplant Patient with COVID-19: A Narrative ReviewSemantic proximity Read ↗

Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies CommitteeSemantic proximity Read ↗

Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.